Stock listing

Ascelia Pharma Ab

Selected listing: ACE · OMXSTO · SEK · SE

Ascelia Pharma Ab (Stockholm:ACE), Health Technology. Latest release Sep 24, 2026: Ascelia Pharma Announces Publication of Orviglance Clinical Study…

ACE:OMXSTOSEKSEUpdated October 3, 2026

Ticker: Stockholm:ACE
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Stockholm
Currency: SEK

About Ascelia Pharma Ab

Ascelia Pharma AB, trading under the ticker ACE, is a public company based in Sweden. Ascelia Pharma focuses on developing innovative treatments in the pharmaceutical sector.

Latest news from Ascelia Pharma Ab

Ascelia Pharma Announces Publication of Orviglance Clinical Study in Journal of Magnetic Resonance Imaging

September 24, 2026

Ascelia Pharma Completes FDA Type A Meeting on Orviglance NDA

September 10, 2026

Ascelia Pharma Announces FDA Has Scheduled Type A Meeting for Orviglance NDA on September 9, 2026

August 17, 2026

Ascelia Pharma Announces Organizational Changes and a Reduced Cost Base

July 15, 2026

Ascelia Pharma Provides Update on the Orviglance NDA

July 3, 2026

All Ascelia Pharma Ab news →

Events

Replays

Ascelia Pharma AB (publ) (ACE) Q2 2026 Earnings Call
Thu, Aug 20, 2026 · 04:00 AM ET
Watch
Ascelia Pharma AB (publ) (ACE) Q1 2026 Earnings Call
Tue, May 12, 2026 · 04:00 AM ET
Watch
Ascelia Pharma AB (publ) (ACE) Q4 2025 Earnings Call
Thu, Feb 05, 2026 · 04:00 AM ET
Watch